Literature DB >> 19487320

Sex differences and the effect of gaboxadol and zolpidem on EEG power spectra in NREM and REM sleep.

D J Dijk1, L M James, S Peters, J K Walsh, S Deacon.   

Abstract

Hypnotics that interact with the GABA(A) receptor have marked effects on the electroencephalogram (EEG) during sleep. It is not known whether the effects of hypnotics on EEG power spectra differ between the sexes. The effects of 5, 10 and 15 mg of gaboxadol (GBX) and 10 mg of zolpidem (ZOL) on EEG power spectra were assessed in a randomized, double-blind, placebo-controlled, 5-way cross-over design study using a phase-advance model of transient insomnia. Sleep stage specific EEG power spectra were computed in 36 men and 45 women. GBX enhanced power density in delta and theta activity in non-rapid eye movement (NREM) and rapid eye movement (REM) sleep, and suppressed sleep spindle activity in NREM sleep. The increase of delta and theta activity in NREM and REM sleep was significantly larger for women than for men but the suppression of spindle activity did not differ between the sexes. After ZOL administration, no sex differences were observed in the reduction of delta and theta activity in NREM sleep, but the increase in sleep spindle activity in NREM sleep was greater in women than in men. These sex dependent and differential effects of GBX and ZOL may be related to their differential affinity for GABA(A) receptor subtypes and their modulation by neurosteroids.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19487320     DOI: 10.1177/0269881109105788

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  16 in total

1.  EEG power spectra response to a 4-h phase advance and gaboxadol treatment in 822 men and women.

Authors:  Junshui Ma; Derk-Jan Dijk; Vladimir Svetnik; Yevgen Tymofyeyev; Shubhankar Ray; James K Walsh; Steve Deacon
Journal:  J Clin Sleep Med       Date:  2011-10-15       Impact factor: 4.062

2.  Clinical profile of suvorexant for the treatment of insomnia over 3 months in women and men: subgroup analysis of pooled phase-3 data.

Authors:  W Joseph Herring; Kathryn M Connor; Ellen Snyder; Duane B Snavely; Ying Zhang; Jill Hutzelmann; Deborah Matzura-Wolfe; Ruth M Benca; Andrew D Krystal; James K Walsh; Christopher Lines; Thomas Roth; David Michelson
Journal:  Psychopharmacology (Berl)       Date:  2017-03-07       Impact factor: 4.530

Review 3.  Sex Differences in Insomnia: from Epidemiology and Etiology to Intervention.

Authors:  Sooyeon Suh; Nayoung Cho; Jihui Zhang
Journal:  Curr Psychiatry Rep       Date:  2018-08-09       Impact factor: 5.285

4.  Differential effects of a dual orexin receptor antagonist (SB-649868) and zolpidem on sleep initiation and consolidation, SWS, REM sleep, and EEG power spectra in a model of situational insomnia.

Authors:  Paolo Bettica; Lisa Squassante; John A Groeger; Brian Gennery; Raphaelle Winsky-Sommerer; Derk-Jan Dijk
Journal:  Neuropsychopharmacology       Date:  2012-01-11       Impact factor: 7.853

5.  Effect of gaboxadol on patient-reported measures of sleep and waking function in patients with Primary Insomnia: results from two randomized, controlled, 3-month studies.

Authors:  Thomas Roth; Christopher Lines; Kristel Vandormael; Paulette Ceesay; Donald Anderson; Duane Snavely
Journal:  J Clin Sleep Med       Date:  2010-02-15       Impact factor: 4.062

6.  Effect of a novel histamine subtype-3 receptor inverse agonist and modafinil on EEG power spectra during sleep deprivation and recovery sleep in male volunteers.

Authors:  Lynette M James; Robert Iannone; John Palcza; John J Renger; Nicole Calder; Kristine Cerchio; Keith Gottesdiener; Richard Hargreaves; M Gail Murphy; Julia Boyle; Derk-Jan Dijk
Journal:  Psychopharmacology (Berl)       Date:  2011-02-08       Impact factor: 4.530

Review 7.  Evaluating the evidence for sex differences: a scoping review of human neuroimaging in psychopharmacology research.

Authors:  Korrina A Duffy; C Neill Epperson
Journal:  Neuropsychopharmacology       Date:  2021-11-03       Impact factor: 7.853

Review 8.  Sleep as a Therapeutic Target in the Aging Brain.

Authors:  Thierno M Bah; James Goodman; Jeffrey J Iliff
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

Review 9.  About sleep's role in memory.

Authors:  Björn Rasch; Jan Born
Journal:  Physiol Rev       Date:  2013-04       Impact factor: 37.312

Review 10.  The Brain-Derived Neurotrophic Factor: Missing Link Between Sleep Deprivation, Insomnia, and Depression.

Authors:  Maryam Rahmani; Farzaneh Rahmani; Nima Rezaei
Journal:  Neurochem Res       Date:  2019-11-28       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.